Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Study shows metabolic, cardiovascular consequences of untreated sleep apnea

Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects.

31 Aug 2017

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.

31 Aug 2017

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL).

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

FDA approves first cell-based gene therapy for use in the United States

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

30 Aug 2017

Moderate intake of carbohydrate and fat associated with better health, says global study

An international study suggests that a diet consisting of a moderate consumption of fat, fruits and vegetables, coupled with avoidance of high levels of carbohydrates, is linked with a decreased risk of death.

30 Aug 2017

Moderate intake of nutrients found to be best for health

Research with more than 135,000 people across five continents has shown that a diet which includes a moderate intake of fat and fruits and vegetables, and avoidance of high carbohydrates, is associated with lower risk of death.

29 Aug 2017

Trial for PTSD treatment with MDMA-assisted psychotherapy receives FDA go-ahead

The United States Food and Drugs Administration FDA has granted permission for phase 3 trials in PTSD (Post traumatic stress disorder) patients using Ecstasy and psychotherapy in a treatment protocol called MDMA-Assisted Psychotherapy PTSD affects thousands of war veterans and other individuals and often leads to fatal outcomes of self-harm and suicides

28 Aug 2017

NSAIDs may not be safe for arthritis patients with cardiovascular risk, study shows

Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, according to late-breaking results from the PRECISION-ABPM study presented today in a Hot Line Session at ESC Congress and published in EHJ.

28 Aug 2017

Lung experts test nicotine patches as potential treatment for sarcoidosis

Doctors believe there is some good to be found in nicotine, the highly addictive drug in tobacco products. Lung experts at The Ohio State University Wexner Medical Center are testing whether nicotine can help people with a chronic inflammatory lung disease called sarcoidosis.

28 Aug 2017

Drug combination improves outcomes in patients with stable coronary or peripheral artery disease

Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in the NEJM.

28 Aug 2017

Biomedical engineering researchers aim to attack two banes of cardiovascular disease

Biomedical engineering researchers will attack two banes of cardiovascular disease -; heart failure after heart attacks and the scourge of resistant high blood pressure -; with $4.8 million in National Institutes of Health grants that begin this fall.

26 Aug 2017

Bioinformatics expert receives $12.8 million grant to continue to lead Diabetic Complications Consortium

Dr. Richard A. McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia at Augusta University, has received a $12.8 million grant to continue to lead a national research initiative focused on reducing the complications of diabetes.

26 Aug 2017

Use of antiseptic mouthwash could put patients at risk for CVD

Nathan Bryan, Ph.D., one of the world's leading experts on the critically important role of Nitric Oxide (NO) in the health of many of the body's organs and systems, said," understanding the vital effects of bacteria in the mouth is essential for health care providers, although it is not widely understood by the public."

26 Aug 2017

Blood Pressure News and Research

Further Reading

Study shows metabolic, cardiovascular consequences of untreated sleep apnea

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

FDA approves first cell-based gene therapy for use in the United States

Moderate intake of carbohydrate and fat associated with better health, says global study

Moderate intake of nutrients found to be best for health

Trial for PTSD treatment with MDMA-assisted psychotherapy receives FDA go-ahead

NSAIDs may not be safe for arthritis patients with cardiovascular risk, study shows

Lung experts test nicotine patches as potential treatment for sarcoidosis

Drug combination improves outcomes in patients with stable coronary or peripheral artery disease

Biomedical engineering researchers aim to attack two banes of cardiovascular disease

Bioinformatics expert receives $12.8 million grant to continue to lead Diabetic Complications Consortium

Use of antiseptic mouthwash could put patients at risk for CVD

Women with history of pre-eclampsia more likely to face atherosclerosis decades after pregnancy

Enhanced levels of NPs in adipose tissue protect against obesity and insulin resistance

Review focuses on possible role of neuroinflammation in Alzheimer's and Parkinson's diseases

Increased enzyme production by the liver causes fatty liver, obesity and insulin resistance

LGB older adults found to be in poorer health than heterosexuals

Two studies offer additional support to lower systolic blood pressure in high-risk patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News